Pharmacists told to order minimum stock quantities to avoid further shortages
The TGA is advising consumers and health professionals that there is a shortage of metformin extended release tablets.
The tablets, which are marketed in Australia under several trade names and by several sponsors, are the subject of a shortage alert.
Pharmacists and wholesalers are requested to order minimum quantities of stock from suppliers to try and minimise the chance of further shortages as supplies become available.
Enquiries regarding supply of metformin extended release tablets should be directed to the product sponsor, the TGA alert advises.
The shortages are due to some suppliers having limited or no stock, resulting in unexpected increased demand on other suppliers which they are not able to fully meet at this time. Suppliers are working closely with their manufacturers to expedite delivery of stock.
There are no safety concerns with the existing supplies of these products.
Eight particular metformin branded products are affected. Click here to see the full list.